• Home
  • News
  • Special Focus
  • Politics & Policy
  • Viewpoint & Comments
Tuesday, January 27, 2026
Mediatracnet
Advertisement
  • Home
  • News
  • Special Focus
  • Politics & Policy
  • Viewpoint & Comments
No Result
View All Result
  • Home
  • News
  • Special Focus
  • Politics & Policy
  • Viewpoint & Comments
No Result
View All Result
Mediatracnet
No Result
View All Result
Home News

COVID-19: WHO, partners hail G7 resolve to share additional 870m vaccine doses

Bassey Udo by Bassey Udo
June 14, 2021
in News
0
COVID-19: WHO, partners hail G7 resolve to share additional 870m vaccine doses

MEDIATRACNET
As the meeting of the Group of 7 countries ended on Sunday, World Health Organisation (WHO) and partners, including pharmaceutical manufacturing companies hailed their resolve to share about 870 million doses of COVID-19 vaccines to expedite a quick end to the pandemic.
In a landmark agreement at the just-concluded summit at Cornwall, UK, the G7 countries, consisting of the world’s largest advanced economies, namely the United Kingdom, Germany, Italy, Canada, France, Japan and the United States resolved to share the vaccine doses internationally, to support global equitable access and to help end the acute phase of the pandemic.
Since February, during its virtual G7 Early Leaders’ Summit at the G20 Global Health Summit, the group pledged to commit one billion doses of the vaccines.
The WHO in a statement welcomed the G7 commitment, along with continued support for equitable access to vaccines in 2021 and 2022, with the resolve to deliver at least half of the 870 million doses by the end of 2021.
WHO, along with COVAX, the vaccine alliance set up by GAVI and the Coalition for Epidemic Preparedness Innovations (CEPI), are part of the Access to COVID-19 Tools (ACT) accelerator to equitably provide COVID-19 diagnostics, treatments and vaccines to all people globally, regardless of their wealth.
COVAX said it would work with the G7 and other countries that have agreed to share doses as rapidly and equitably as possible.
“This will help address short-term supply constraints currently impacting the global response to COVID-19 and minimize the prospect of future deadly variants.
CEO of Gavi, Seth Berkley, said, “this is an important moment of global solidarity and a critical milestone in the push to ensure those most at risk, everywhere are protected.”
CEO of CEPI, Richard Hatchett, said: “As we strive towards our goal of ending the acute phase of the pandemic, we look forward to working with countries to ensure these doses pledged are quickly turned into doses delivered.
“This is a historic moment as leaders of some of the wealthiest counties come together to ensure that all parts of the world have access to life-saving vaccines.
“This pandemic has shown us that we cannot set national against international interests. With a disease like COVID-19, we have to ensure that we get it under control everywhere.
WHO Director-General, Tedros Ghebreyesus, said: “Many other countries are now facing a surge in cases and they are facing it without vaccines.
“We are in the race of our lives, but it’s not a fair race, and most countries have barely left the starting line. We welcome the generous announcements about donations of vaccines and thank leaders.”
At the end of the meeting, Canadian Prime Minister, Justin Trudeau told a news conference the G7 Summit pledged to take urgent action on the COVID-19 pandemic, climate, and possibly China.
In a 25-page communiqué, the summit said they were committed to ending the pandemic and prepare for the future while supporting a green revolution aimed at moving their economies on the path of recovery.
Also, they pledged to share more COVID-19 vaccines with countries in need over the next year.
“I want to be clear, this global commitment on vaccines is in addition to and in parallel with our vaccine rollout at home. We have millions of doses being delivered into the country each week, and every day more and more people get their first and second shots,” Trudeau said.

Previous Post

Frivolous tax claims: FIRS demands payment of 50% of disputed tax into court account before hearing

Next Post

G7, partners to invest over $80bn in African businesses over next 5 years

Bassey Udo

Bassey Udo

Bassey Udo is a Journalist, Communication & Media Practitioner PERSONAL DETAILS DATE OF BIRTH: March 3, 1965 GENDER: Male NATIONALITY: Nigerian GSM: +234 802 313 7335; 07032308000 EMAIL: bassey.udo@gmail.com CONTACT ADDRESS: Plot 743 Coral Park Street, Lugbe CRD, Abuja, FCT 900128 A multiple award winning investigative reporter with specialised interest in Business & Economy, Energy & Power, Oil, Gas, Mining & Extractive Industry, Environment & Climate Change, etc. at various times for some of Nigeria’s elite newspapers and magazines, including Post Express, NewsAfrica magazine, Independent, 234NEXT and Premium Times. A member of the Nigerian Guild of Editors (NGE), Nigeria Union of Journalists (NUJ), Nigerian Institute of Public Relations (NIPR) and Society of International Law & Diplomacy (SILD). He is also a distinguished Alumnus of the U.S. International Visitors Leadership Programme (IVLP) 2017.

Next Post
COVID-19: WHO, partners hail G7 resolve to share additional 870m vaccine doses

G7, partners to invest over $80bn in African businesses over next 5 years

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Browse by Category

  • Business & Economy
  • Energy Transition & Global Environment
  • Labour & Productivity
  • News
  • Politics
  • Politics & Policy
  • Religion
  • Science & Technology
  • Social Business
  • Special Focus
  • Sport & Entertainment
  • Viewpoint & Comments
  • Visualisations
  • World
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 Mediatracnet - tracking news for community value... Powered by Zilisoft Tech.

No Result
View All Result
  • Home
  • News
  • Special Focus
  • Politics & Policy
  • Viewpoint & Comments

© 2023 Mediatracnet - tracking news for community value... Powered by Zilisoft Tech.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.